Lancashire and South Cumbria
Formulary
 
back
4 Central nervous system
04-09-01 Levodopa

Co-Beneldopa
Formulary

Capsules 62.5mg (12.5/50), 125mg (25/100), 250mg (50/200)
Dispersible tablets 62.5mg (12.5/50), 125mg(25/100)
Modified-release capsules 125mg (25/100)

Parkinson's disease.


Amber 0 View adult BNF  View SPC online  View childrens BNF
Co-Careldopa
Formulary

Tablets 62.5mg (12.5/50), 110mg (10/100), 125mg (25/100), 275mg (25/250)
Modified-release tablets 125mg (25/100), 250mg (50/200)

Parkinson's disease.


Amber 0 View adult BNF  View SPC online  View childrens BNF
Co-Careldopa and Entacapone
Formulary

Tablets (multiple strength combinations available).

Parkinson's disease.


Amber 0 View adult BNF  View SPC online  View childrens BNF
Foslevodopa–Foscarbidopa Produodopa®
Formulary

Solution for infusion 240mg/ml + 12mg/ml

Parkinson's disease.

Link  NICE TA934: Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms

Red View adult BNF  View SPC online  View childrens BNF
Levodopa-Carbidopa- Entacapone Intestinal Gel (LECIG)
Formulary
Treatment with LECIG for Parkinson’s Disease may be delivered and managed through any acute provider trust which treats patients with Parkinson’s disease under either neurology or elderly care services. Eligibility must be determined through a specialist Parkinson’s clinician in an agreed networked approach with a specialist Parkinson's service in a regional specialised neurology centre. This may be through direct clinical assessment by clinicians with appropriate expertise within the network or through a Parkinson’s disease MDT arrangement managed through a specialised neurology centre.

Red View adult BNF  View SPC online  View childrens BNF
Levodopa-Carbidopa Intestinal Gel (LCIG)
Formulary
Treatment with LCIG for Parkinson’s Disease may be delivered and managed through any acute provider trust which treats patients with Parkinson’s disease under either neurology or elderly care services. Eligibility must be determined through a specialist Parkinson’s clinician in an agreed networked approach with a specialist Parkinson's service in a regional specialised neurology centre. This may be through direct clinical assessment by clinicians with appropriate expertise within the network or through a Parkinson’s disease MDT arrangement managed through a specialised neurology centre.

Red View adult BNF  View SPC online  View childrens BNF